BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

BioSpec Global Solutions Inc. Signs Letter of Intent with Beijing Titan Instruments Co., Ltd. for Multimillion Dollar Market


4/19/2010 10:47:44 AM

NEW YORK and MONTREAL, April 19 /PRNewswire-FirstCall/ - BioSpec Global Solutions Inc., and partner ICBS Ltd. (OTCPK: ICBT), announced today that it has signed a letter of intent with Beijing Titan Instruments Co., Ltd for distribution in China of the TOGS(TM) 3000 bio-photonic incubation & detection systems, The TOGS(TM) 3000 has 100% accuracy in the detection of Total Coli forms and E. Coli bacteria in water.

"This will establish a gateway to the vast Chinese market" said Don Saunders, President and CEO.

World pressure on China over food and water safety is presently a good example of need for our type of detection system.

"The timing for commercialization is excellent. The World Health Organization has declared "safe drinking water is a human right" and the United Nations is struggling with its mandate to protect drinking water quality in over 100 million wells worldwide. Governments of the world are being pressured to conform to these directives" said Saunders.

Although the final sales numbers are not completed, BioSpec is facing a multi billion dollar market.

The TOGS(TM) 3000 has been verified by Ryerson University, Agriculture Canada and Saskatchewan Department of Health. It has been accepted for use for drinking water analysis by EPA in the USA when used in conjunction with our EPA approved reagent and method. The TOGS(TM) 3000 has been used in a research project by the World Health Organization in Hawaii and by OCETA in India. Agents and distributors are being established to set up a global marketing network.

The company holds worldwide patents on the TOGS(TM) 3000 and TOGS9000(TM).

NB. This news release includes statements that constitute forward-looking statements. Please be aware that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary materially from those in the forward-looking statements as a result of any number of factors, including the risk factors contained in the Company's disclosure documents.

CONTACT: Don Saunders, President & CEO, (514) 932-4402, www.icbs.ca;
Source: BioSpec Global Solutions Inc., www.biospecglobal.com


Read at BioSpace.com

Related News

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->